Generation Bio Co Stock Retained Earnings
| GBIO Stock | USD 4.21 0.23 5.18% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Generation Bio's long-term financial health and intrinsic value.
| Last Reported | Projected for Next Year | ||
| Retained Earnings | -703 M | -667.9 M | |
| Retained Earnings Total Equity | -400.3 M | -420.3 M |
Generation | Retained Earnings | Build AI portfolio with Generation Stock |
Generation Bio Co Company Retained Earnings Analysis
Generation Bio's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Generation Bio Retained Earnings | (703.04 M) |
Most of Generation Bio's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Generation Bio Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generation Retained Earnings Driver Correlations
Understanding the fundamental principles of building solid financial models for Generation Bio is extremely important. It helps to project a fair market value of Generation Stock properly, considering its historical fundamentals such as Retained Earnings. Since Generation Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Generation Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Generation Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
| Competition |
Based on the latest financial disclosure, Generation Bio Co has a Retained Earnings of (703.04 Million). This is 175.49% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The retained earnings for all United States stocks is 107.54% higher than that of the company.
Generation Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Generation Bio's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Generation Bio could also be used in its relative valuation, which is a method of valuing Generation Bio by comparing valuation metrics of similar companies.Generation Bio is currently under evaluation in retained earnings category among its peers.
Generation Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Generation Bio from analyzing Generation Bio's financial statements. These drivers represent accounts that assess Generation Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Generation Bio's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 772.7M | 398.6M | 228.4M | 70.6M | 81.2M | 77.2M | |
| Enterprise Value | 709.8M | 104.3M | 216.9M | 87.9M | 101.1M | 96.0M |
Generation Bio ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Generation Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Generation Bio's managers, analysts, and investors.Environmental | Governance | Social |
Generation Fundamentals
| Return On Equity | -0.7 | ||||
| Return On Asset | -0.19 | ||||
| Profit Margin | (2.93) % | ||||
| Operating Margin | (1.77) % | ||||
| Current Valuation | (41.38 M) | ||||
| Shares Outstanding | 6.7 M | ||||
| Shares Owned By Insiders | 14.30 % | ||||
| Shares Owned By Institutions | 72.13 % | ||||
| Number Of Shares Shorted | 814.51 K | ||||
| Price To Book | 0.39 X | ||||
| Price To Sales | 1.15 X | ||||
| Revenue | 19.89 M | ||||
| Gross Profit | (24.16 M) | ||||
| EBITDA | (74.26 M) | ||||
| Net Income | (131.67 M) | ||||
| Cash And Equivalents | 301.17 M | ||||
| Cash Per Share | 5.07 X | ||||
| Total Debt | 93.56 M | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 17.93 X | ||||
| Book Value Per Share | 10.94 X | ||||
| Cash Flow From Operations | (88.56 M) | ||||
| Short Ratio | 0.65 X | ||||
| Earnings Per Share | (10.80) X | ||||
| Target Price | 70.0 | ||||
| Number Of Employees | 115 | ||||
| Beta | 2.6 | ||||
| Market Capitalization | 28.21 M | ||||
| Total Asset | 231.2 M | ||||
| Retained Earnings | (703.04 M) | ||||
| Working Capital | 157.85 M | ||||
| Net Asset | 231.2 M |
About Generation Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Generation Bio Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Generation Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Generation Bio Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Generation Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Generation Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generation Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Generation Stock
Moving against Generation Stock
| 0.42 | CVS | CVS Health Corp Aggressive Push | PairCorr |
The ability to find closely correlated positions to Generation Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Generation Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Generation Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Generation Bio Co to buy it.
The correlation of Generation Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Generation Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Generation Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Generation Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Generation Bio Piotroski F Score and Generation Bio Altman Z Score analysis. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.80) | Revenue Per Share | Quarterly Revenue Growth 1.149 | Return On Assets | Return On Equity |
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.